These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38567601)

  • 1. Comparison of intravesical chemotherapy regimens after radical nephroureterectomy for upper tract urothelial carcinoma and analysis of risk factors for postoperative recurrence.
    Jiang SC; Liao YG; Luo J; Hu D; Wang YD; He K
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2387-2395. PubMed ID: 38567601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single Early Intravesical Instillation of Epirubicin for Preventing Bladder Recurrence after Nephroureterectomy in Upper Urinary Tract Urothelial Carcinoma.
    Lee JH; Lee CU; Chung JH; Song W; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Sung HH
    Cancer Res Treat; 2024 Jul; 56(3):877-884. PubMed ID: 38271926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of BCG for non-muscle invasive bladder cancer following nephroureterectomy for upper tract urothelial carcinoma.
    Massari M; O'Malley P; Benidir T; Su LM; Gao H; Crispen PL
    Urol Oncol; 2024 Sep; 42(9):289.e7-289.e12. PubMed ID: 38802293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and oncologic impact of chronic kidney disease for upper tract urothelial carcinoma in endemic area.
    Lee IW; Wang HJ; Liu HY; Chang YL; Wu YT; Chen YT; Cheng YT; Kang CH; Chuang YC; Luo HL
    J Formos Med Assoc; 2024 Jul; 123(7):758-763. PubMed ID: 38044211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Yamashita S; Ito A; Mitsuzuka K; Tochigi T; Namima T; Soma F; Aizawa M; Ioritani N; Kaiho Y; Arai Y
    Int J Urol; 2016 May; 23(5):378-84. PubMed ID: 26780531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial.
    Yamashita S; Ito A; Mitsuzuka K; Ioritani N; Ishidoya S; Ikeda Y; Numahata K; Orikasa K; Tochigi T; Soma F; Namima T; Arai Y
    Jpn J Clin Oncol; 2017 Sep; 47(9):870-875. PubMed ID: 28903527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern and risk factors of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a large Chinese center experience.
    Fang D; Xiong GY; Li XS; Chen XP; Zhang L; Yao L; He ZS; Zhou LQ
    J Formos Med Assoc; 2014 Nov; 113(11):820-7. PubMed ID: 24360737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Xylinas' nomogram accurately predict intravesical recurrence risk after radical nephroureterectomy for primary upper urinary tract urothelial carcinoma when applied to Asian populations?
    Lai S; Wu P; Diao T; Seery S; Liu J; Hou H; Liu M; Wang J
    Jpn J Clin Oncol; 2021 Mar; 51(3):469-477. PubMed ID: 32734304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Monocyte-to-lymphocyte Ratio Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Liu J; Wu P; Lai S; Song X; Fu C; Wang X; Liu S; Hou H; Liu M; Wang J
    Clin Genitourin Cancer; 2021 Jun; 19(3):e156-e165. PubMed ID: 33121908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Miyake M; Tatsumi Y; Matsumoto H; Nagao K; Matsuyama H; Inamoto T; Azuma H; Yasumoto H; Shiina H; Fujimoto K;
    BJU Int; 2018 May; 121(5):764-773. PubMed ID: 29281857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
    Wu WJ; Ke HL; Yang YH; Li CC; Chou YH; Huang CH
    J Urol; 2010 Jan; 183(1):56-61. PubMed ID: 19913833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
    Chen H; Wang M; Weng T; Wei Y; Yang L; Ren K; Tang Z; Gou X
    Urol Int; 2022; 106(2):186-194. PubMed ID: 34492655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative risk classification for intravesical recurrence after laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma in a multi-institutional cohort.
    Somiya S; Kobori G; Ito K; Nakagawa H; Takahashi T; Koterazawa S; Takaoka N; Haitani T; Nagahama K; Ito M; Megumi Y; Higashi Y; Moroi S; Akao T; Yamada H; Kanno T
    Int J Urol; 2023 Oct; 30(10):853-858. PubMed ID: 37278493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.
    Jiang Y; Yao Z; Zhu X; Wu B; Bai S
    Int J Surg; 2020 Apr; 76():28-34. PubMed ID: 32081714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma.
    Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Hagiwara M; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Hasegawa S; Nakajima Y; Oya M
    Ann Surg Oncol; 2014 Sep; 21(9):3151-8. PubMed ID: 24682698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Adjuvant Systemic Chemotherapy on Intravesical Recurrence After Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.
    Yamaguchi N; Morizane S; Yumioka T; Shimizu R; Teraoka S; Iwamoto H; Hikita K; Honda M; Takenaka A
    Anticancer Res; 2023 Apr; 43(4):1725-1730. PubMed ID: 36974830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Different Prophylactic Intravesical Chemotherapy Regimens for Bladder Cancer Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinomas: A Retrospective 2-center Study.
    Huang Y; Cen J; Liu Z; Wei J; Chen Z; Feng Z; Lu J; Fang Y; Zhou F; Luo J; Mo C; Chen W
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819844483. PubMed ID: 30987527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S; Mita K; Shigeta M; Usui T
    Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy.
    Yu TY; Wang HJ; Sung MT; Chuang YC; Chen YT; Cheng YT; Kang CH; Liu HY; Chang YL; Luo HL
    Int J Urol; 2024 Apr; 31(4):410-418. PubMed ID: 38169055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.